Working together with laboratories, Thermo Fisher Scientific played a critical role in helping to solve the world’s greatest challenges during the COVID‑19 pandemic. As a leader in the industry, we will continue to be here for you—delivering trusted molecular diagnostic solutions that help you guide effective patient outcomes. 

Revolutionize patient care through clinically relevant molecular testing


Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices. 

While traditional methods, such as culture, continue to have an important role in diagnosis of infectious diseases, PCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.

Explore the resources below to learn more about the role molecular testing can serve in patient management and care decisions.



Panel discussions: “Diagnostics- fulfilling its potential”

In this 3-part educational series hosted in collaboration with Arizona State University, leading national experts in the chosen topics tackle the important challenges surrounding when, how, and why to use diagnostics to improve the current healthcare system. 

View now


Educational resources by disease and focus areas

The respiratory landscape is ever-evolving, seasonal, and unpredictable.

Respiratory tract infections

Molecular testing has improved diagnosis of circulating respiratory viruses and atypical bacteria.

Learn more ›
Request RTI infographic ›


Discover the new frontier of using PCR for the detection of urinary tract infections.

Urinary tract infections

Discover how to use PCR for the detection of urinary tract infections and the growing evidence for this molecular testing method.

Learn more › 
Request UTI infographic › 

Gastrointestinal tract infections

Gastrointestinal tract infections

There are challenges in diagnosing infectious gastroenteritis. Molecular testing can enable laboratories to address those challenges.

Learn more ›
Request GI infographic ›


Sexually transmitted and vaginal infections

Sexually transmitted/Vaginal infections

Early and accurate detection and differentiation is the first step toward understanding the cause of infection and determining  next steps.

Learn more ›
Request STI infographic ›
Request VM infographic ›

Viral hepatitis molecular testing

Viral hepatitis molecular testing

Molecular diagnostic testing for viral hepatitis can be used to confirm hepatitis infection when serology results are unclear, and to monitor viral load levels.


Learn more ›

HIV molecular testing

HIV molecular testing

Explore how molecular genomic and genetic testing serve as powerful tools in the global fight to end HIV.


Learn more ›
Request HIV drug resistance infographic ›

Learn about the detection of antibiotic resistance genes through molecular techniques.

Antibiotic resistance

Next step for Molecular Diagnostics and Antimicrobial Resistance: How to Maximize Advanced Technology in the Lab.

Watch webinar ›


eBook and learning guides

e-Book: The value of molecular testing

A compilation of informative interviews with key medical experts, this is intended to aid lab professionals and clinicians working in all types of laboratories to better understand the clinical value of molecular testing.

Learn more

HIV Learning Guide: A Primer for Healthcare Professionals

This comprehensive HIV learning guide is offered with case studies in four modules and is edited by HIV healthcare experts from Senegal, Nigeria, India, and Brazil.

Download guide


Blogs, articles, and white papers

The Health Benefits and Economic Value of Pharmacogenomics

PGx is a core element of precision medicine and is designed to improve the individual’s response to medication by assessing drug-compatibilities with the person’s genomic profile.

Read blog 

Is it Time to Substitute Culture With Molecular Diagnostics?

Read why laboratories newly equipped with MDx infrastructure may be in an advantageous position to expand testing menus to include infectious diseases beyond SARS-CoV-2.

Read blog

Style Sheet for Global Design System